# Molecular characteristics and Helicobacter pylori infection rates in patients with gastric cancer in Western Poland: a comparative analysis of gastrectomy specimens across two decades

**Authors:** Jan Majewski, Marta Moszyńska, Kamila Stawczyk-Eder, Aldona Woźniak, Agnieszka Dobrowolska, Elżbieta Kaczmarek, Piotr Eder

PMC · DOI: 10.3389/fonc.2026.1651941 · 2026-02-03

## TL;DR

This study compared gastric cancer characteristics in Western Poland over two decades and found no significant changes in Helicobacter pylori infection rates or early detection despite technological advances.

## Contribution

The study provides a longitudinal analysis of gastric cancer molecular features and H. pylori infection rates in a rapidly developing region.

## Key findings

- Ki-67 proliferation index significantly increased in cancers diagnosed in 2016-2020.
- Higher Ki-67 levels correlated with intestinal-type tumors, p53 expression, H. pylori infection, and angiogenesis.
- Molecular characteristics and H. pylori-positive tumor rates remained largely unchanged over two decades.

## Abstract

Gastric cancer incidence and characteristics vary due to environmental factors, and technical advances facilitate early detection of the disease. This study aimed to assess whether significant socio-economic changes and technological advancements in Poland — one of the most rapidly developing countries worldwide — affected the molecular characteristics and detection rates of early gastric cancer sub-types in Western Poland.

Ninety-two patients undergoing gastrectomy for gastric cancer in 1998–2002 and 2016–2020 were studied. Surgical specimens were re-analyzed for histopathological features, including tumor type, grade, and stage (up-dated World Health Organization [WHO] classification). Immunohistochemical markers (Ki-67, p53, E-cadherin, CD10, CD31, bcl-2) and antigens for Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) were evaluated. Microsatellite instability (MSI) was assessed via PMS2/MSH2 protein expression.

The groups were comparable in age and gender, with male predominance. Histological features, H. pylori and EBV colonization, and most molecular markers showed no significant differences. However, Ki-67 proliferation index significantly increased in cancers diagnosed in 2016-2020, correlating with intestinal-type tumors and p53 expression. In this group, higher Ki-67 levels were also linked to H. pylori infection, microsatellite stability, and increased angiogenesis.

Despite advancements in H. pylori research and technology over 20 years, no improvement was observed in H. pylori-positive tumor rates or early gastric cancer detection in Western Poland. Although molecular characteristics remained largely unchanged, the increased proliferation index in recently diagnosed cancers merits further study.

## Linked entities

- **Genes:** Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345], TP53 (tumor protein p53) [NCBI Gene 7157], shg (shotgun) [NCBI Gene 37386], MME (membrane metalloendopeptidase) [NCBI Gene 4311], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395], MSH2 (mutS homolog 2) [NCBI Gene 4436]
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, MSH6 (mutS homolog 6) [NCBI Gene 2956] {aka GTBP, GTMBP, HNPCC5, HSAP, LYNCH5, MMRCS3}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395] {aka HNPCC4, LYNCH4, MLH4, MMRCS4, PMS-2, PMSL2}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, MLH1 (mutL homolog 1) [NCBI Gene 4292] {aka COCA2, FCC2, HNPCC, HNPCC2, LYNCH2, MLH-1}, MSH2 (mutS homolog 2) [NCBI Gene 4436] {aka COCA1, FCC1, HNPCC, HNPCC1, LCFS2, LYNCH1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** infection (MESH:D007239), mucinous adenocarcinoma (MESH:D002288), metastasis (MESH:D009362), intestinal metaplasia (MESH:D007410), Tumor-Node-Metastasis (MESH:D008207), gastrointestinal malignancies (MESH:D005770), papillary adenocarcinoma (MESH:D000231), adenocarcinoma (MESH:D000230), cancer (MESH:D009369), AD (MESH:D000544), undifferentiated carcinoma (MESH:D002277), intestinal cancer (MESH:D007414), atrophic gastritis (MESH:D005757), chronic inflammation (MESH:D007249), dysplasia (MESH:D015792), H. pylori (MESH:D016481), epigastric pain (MESH:D010146), metaplasia (MESH:D008679), obesity (MESH:D009765), nausea (MESH:D009325), gastric cancer infected (MESH:D013274), gastric carcinogenesis (MESH:D063646), fatigue (MESH:D005221)
- **Chemicals:** HE (-), hematoxylin (MESH:D006416), alcohol (MESH:D000438), eosin (MESH:D004801), formalin (MESH:D005557), paraffin (MESH:D010232), salt (MESH:D012492)
- **Species:** human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Helicobacter pylori (species) [taxon 210], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909228/full.md

---
Source: https://tomesphere.com/paper/PMC12909228